Eli Lilly is one step closer to bringing an oral weight loss medicine to the booming obesity drug market. A clinical trial ...

Drugmaker Eli Lilly said Thursday that things are looking good for their latest weight loss drug that would be available as a ...

Kelly Clarkson's Ex-Husband Brandon Blackstock Dead At 48 What You're Really Eating When You Order Taco Bell Helicopter ...

Key Takeaways The S&P 500 slid 0.1% on Thursday, Aug. 7, 2025, as new tariffs took effect, raising import duties on goods from numerous U.S. trading partners.Shares of pharmaceutical giant Eli Lilly ...

A slew or company results were causing big market moves ahead of the opening bell Thursday, and for many, earnings-beat ...

The Dow and S&P 500 eased on Thursday, as shares of Eli Lilly dropped after data from its oral weight loss drug disappointed, ...

David Risinger, Leerink Partners senior research analyst, joins 'Power Lunch' to discuss how competitive Eli Lilly's business ...

Asad Haider, Goldman Sachs analyst, joins 'Money Movers' to discuss Eli Lilly tumbling on trial results and his outlook for ...

Despite reporting better-than-expected Q2 results, Eli Lilly is under pressure amid concerns over late-stage trial data for ...

Lilly has been chasing—and gaining on—its chief metabolic medicine rival Novo Nordisk and its counterpart GLP-1s Ozempic and ...

The Washington Post reported the CMS is considering a plan that could allow Medicare plans to pay for the drugs.